Healthcare Realty Trust Incorporated (NYSE:HR)‘s stock had its “buy” rating reissued by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Friday. They currently have a $34.00 price objective on the real estate investment trust’s stock. Stifel Nicolaus’ target price points to a potential upside of 4.94% from the company’s previous close.

HR has been the topic of several other research reports. Zacks Investment Research cut shares of Healthcare Realty Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, September 13th. Jefferies Group LLC reissued a “hold” rating and set a $34.00 price target (down previously from $36.00) on shares of Healthcare Realty Trust in a research report on Thursday, August 10th. Mizuho reissued a “hold” rating and set a $35.00 price target on shares of Healthcare Realty Trust in a research report on Friday, October 27th. BidaskClub raised shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Healthcare Realty Trust in a research report on Wednesday, August 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $33.43.

Shares of Healthcare Realty Trust (NYSE HR) traded up $0.03 on Friday, reaching $32.40. 382,213 shares of the company’s stock traded hands, compared to its average volume of 773,851. The company has a market capitalization of $4,041.44, a price-to-earnings ratio of 20.61 and a beta of 0.32.

Healthcare Realty Trust (NYSE:HR) last announced its earnings results on Wednesday, November 1st. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.01). Healthcare Realty Trust had a return on equity of 6.62% and a net margin of 26.70%. The business had revenue of $106.95 million for the quarter, compared to analyst estimates of $108.97 million. During the same period last year, the firm earned $0.39 EPS. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. analysts forecast that Healthcare Realty Trust will post 1.59 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/03/stifel-nicolaus-reaffirms-buy-rating-for-healthcare-realty-trust-incorporated-hr.html.

In related news, Director John Knox Singleton acquired 3,450 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, August 15th. The shares were purchased at an average cost of $31.88 per share, for a total transaction of $109,986.00. Following the acquisition, the director now owns 17,693 shares in the company, valued at $564,052.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.85% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Glenmede Trust Co. NA raised its holdings in Healthcare Realty Trust by 9.4% in the 2nd quarter. Glenmede Trust Co. NA now owns 3,283 shares of the real estate investment trust’s stock valued at $114,000 after buying an additional 283 shares during the period. Fiduciary Trust Co. purchased a new stake in Healthcare Realty Trust in the 2nd quarter valued at about $113,000. Riverhead Capital Management LLC raised its holdings in Healthcare Realty Trust by 506.1% in the 3rd quarter. Riverhead Capital Management LLC now owns 3,600 shares of the real estate investment trust’s stock valued at $123,000 after buying an additional 3,006 shares during the period. Hexavest Inc. purchased a new stake in Healthcare Realty Trust in the 3rd quarter valued at about $126,000. Finally, Daiwa Securities Group Inc. raised its holdings in Healthcare Realty Trust by 16.2% in the 3rd quarter. Daiwa Securities Group Inc. now owns 4,300 shares of the real estate investment trust’s stock valued at $146,000 after buying an additional 600 shares during the period. Hedge funds and other institutional investors own 91.74% of the company’s stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.

Analyst Recommendations for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.